Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment

Authors

Traci C. Green, Brandeis University
Bratberg, University of Rhode Island
Deborah S. Finnell, Johns Hopkins School of Nursing

Document Type

Editorial

Date of Original Version

4-2-2020

Abstract

We highlight the critical roles that pharmacists have related to sustaining and advancing the changes being made in the face of the current COVID-19 pandemic to ensure that patients have more seamless and less complex access to treatment. Discussed herein is how the current COVID-19 pandemic is impacting persons with substance use disorders, barriers that persist, and the opportunities that arise as regulations around treatments for this population are eased.

Publication Title, e.g., Journal

Substance Abuse

Volume

41

Issue

2

Citation/Publisher Attribution

Green, Traci C., Bratberg, and Deborah S. Finnell. "Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment." Substance Abuse 41, 2 (2020): 147-149. doi: 10.1080/08897077.2020.1752351.